In 2007, the nosology for HIV-1-associated neurocognitive disorders (HAND) was updated
to a primarily neurocognitive disorder. However, currently available diagnostic tools lack the …

Background: Electroconvulsive therapy (ECT) is one of the most effective treatments for
major depressive disorder. Recently, there has been increasing attention to evaluate the …

HIV is associated with disruptions in cognition and brain function. Marijuana use is highly
prevalent in HIV but its effects on resting brain function in HIV are unknown. Brain function …

Objective Asymptomatic neurocognitive impairment (ANI) is a predominant form of cognitive
impairment in young HIV-infected patients. However, the neurophysiological mechanisms …

Introduction Numerous structural studies have already reported volumetric reduction in
cerebellum with aging. However, there are still limited studies particularly focusing on …

Electroconvulsive therapy (ECT), a rapidly acting and effective treatment for major
depressive disorder (MDD), is frequently accompanied by cognitive impairment. Recent …

Older HIV-infected patients are at risk for both HIV-associated neurocognitive disorder
(HAND) and Alzheimer's disease. We investigated neuroimaging and neuropsychological …

The age of the HIV-infected population is increasing. Although many studies document gray
matter volume (GMV) changes following HIV infection, GMV also declines with age. Findings …

Central nervous system (CNS) sequelae continue to be common in HIV-infected individuals
despite combination antiretroviral therapy (cART). These sequelae include HIV-associated …

Purpose: Neuroimaging elucidations have shown structural and functional brain alterations
in HIV-infected (HIV+) individuals when compared to HIV-negative (HIV–) controls. However …